Director · Attovia Therapeutics, Inc. · Common Stock
Side
C
Value
—
Shares
478.5K
Price
—
Executed
Aug 6, 2026
Disclosed
Aug 13, 2026
Disclosure timeline7 days from execution to publication · legal deadline 2 business days
Aug 6 executedAug 13, 2026 disclosed
ATTO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Derivative conversion — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 23.4% of prior position
Filing timing+6 / 15
Disclosed 5 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 24 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Walsh Colin filed this Form 4 reporting a derivative conversion of ATTO on Aug 6, 2026. It became public on Aug 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Walsh Colincik:0001866174
Issuer
Attovia Therapeutics, Inc.cik:0002058707
Revision history · 0
No field has changed since this record was first ingested.
